Collegium Pharmaceutical, Inc. Earnings Per Share (Diluted)
Collegium Pharmaceutical, Inc. (COLL) reported Earnings Per Share (Diluted) of -$0.46 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.46, a 235.29% decline year-over-year.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.40, a 471.43% increase year-over-year.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.46, a 27.78% increase year-over-year.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.84, a 211.11% increase year-over-year.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for fiscal 2025 was $1.73, a 6.99% decline from fiscal 2024.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for fiscal 2024 was $1.86, a 44.19% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for fiscal 2023 was $1.29.
- Collegium Pharmaceutical, Inc. earnings per share, diluted for fiscal 2022 was -$0.74, a 139.78% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.46 10-Q · filed 2026-08-06 | -$0.02 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $0.40 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $0.46 10-K · filed 2026-02-26 | $1.73 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.84 10-K · filed 2026-02-26 | $1.28 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.34 10-Q · filed 2026-08-06 | $0.44 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $0.07 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $0.36 10-K · filed 2026-02-26 | $1.86 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.27 10-K · filed 2026-02-26 | $1.51 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.52 10-K · filed 2026-02-26 | $1.24 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.71 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.82 10-K · filed 2025-02-27 | $1.29 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $0.53 10-K · filed 2025-02-27 | $0.46 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.34 10-K · filed 2025-02-27 | -$0.13 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.51 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$0.21 10-K · filed 2024-02-22 | -$0.74 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $0.01 10-K · filed 2024-02-22 | -$0.52 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$0.15 10-K · filed 2024-02-22 | -$0.54 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$0.39 10-K · filed 2024-02-22 | |||
| 2021-12-31 | -$0.73 10-K · filed 2023-02-23 | $1.86 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $0.22 10-K · filed 2023-02-23 | $2.42 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $1.79 10-K · filed 2023-02-23 | $2.20 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.41 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $0.20 10-K · filed 2022-02-24 | $0.76 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $0.32 10-K · filed 2022-02-24 | $0.56 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $0.23 10-K · filed 2022-02-24 | $0.24 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.01 10-K · filed 2022-02-24 | |||
| 2019-12-31 | -$0.68 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$0.18 10-Q · filed 2020-11-05 | -$0.62 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.14 10-Q · filed 2020-08-05 | -$0.43 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$0.29 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.27 10-K · filed 2020-02-27 | -$1.19 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$0.50 10-K · filed 2020-02-27 | |||
| 2018-06-30 | -$0.40 10-K · filed 2020-02-27 | |||
| 2018-03-31 | -$0.57 10-K · filed 2020-02-27 | |||
| 2016-03-31 | -$0.68 10-Q · filed 2016-05-11 | |||
| 2015-12-31 | -$0.46 10-K · filed 2017-03-10 | |||
| 2015-09-30 | -$0.46 10-K · filed 2017-03-10 | |||
| 2015-06-30 | -$0.45 10-K · filed 2017-03-10 | -$0.12 derived: net income ÷ weighted average shares · filed 2017-03-10 | ||
| 2015-03-31 | -$0.65 10-K · filed 2017-03-10 | |||
| 2014-03-31 | -$5.03 10-Q/A · filed 2015-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |